menu
    • menu

    Company profile for Inflazome

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Inflazome is a biotech company leading the development of orally available drugs to address clinical unmet needs in inflammatory diseases by targeting inflammasomes. Inflammasomes are understood to drive many chronic inflammatory conditions, from Parkinson’s and Alzheimer’s to asthma, inflammatory bowel disease, chronic kidney disease, cardiovascular disease, arthritis and NASH. Inflazome has two clinical-stage investigati...
    Inflazome is a biotech company leading the development of orally available drugs to address clinical unmet needs in inflammatory diseases by targeting inflammasomes. Inflammasomes are understood to drive many chronic inflammatory conditions, from Parkinson’s and Alzheimer’s to asthma, inflammatory bowel disease, chronic kidney disease, cardiovascular disease, arthritis and NASH. Inflazome has two clinical-stage investigational drugs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    InflazomeIreland Flag
    Country
    Country
    Ireland
    Address
    Address
    Inflazome Ltd. 32 Kildare St Dublin 2, Ireland D02 R859
    Telephone
    Telephone
    +353 1 687 5002
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://inflazome.com/press-release-21-sep-2020.html
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Roche doubles down on promising inflammation field with Inflazome buy
    Roche doubles down on promising inflammation field with Inflazome buy

    25 Sep 2020

    // D.W. House SEEKING ALPHA

    https://seekingalpha.com/news/3616633-roche-doubles-down-on-promising-inflammation-field-inflazome-buy

    D.W. House SEEKING ALPHA
    25 Sep 2020
    Share Share
    Roche pays €380M for NLRP3 biotech Inflazome, claiming a leading position
    Roche pays €380M for NLRP3 biotech Inflazome, claiming a leading position

    22 Sep 2020

    // N. P. Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/roche-pays-eu380m-for-nlrp3-biotech-inflazome-claiming-a-leading-position-hot-field

    N. P. Taylor FIERCE BIOTECH
    22 Sep 2020
    Share Share
    Inflazome Announces Its Acquisition By Roche
    Inflazome Announces Its Acquisition By Roche

    21 Sep 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200921005264/fr

    BUSINESSWIRE
    21 Sep 2020
    Share Share
    FDA Grants Orphan Drug Designation for Inflazome’s Inzomelid for (CAPS)
    FDA Grants Orphan Drug Designation for Inflazome’s Inzomelid for (CAPS)

    14 Jul 2020

    // BUSINESSLWIRE

    https://www.businesswire.com/news/home/20200713005569/en/FDA-Grants-Orphan-Drug-Designation-Inflazome%E2%80%99s-Inzomelid

    BUSINESSLWIRE
    14 Jul 2020
    Share Share
    FDA Grants Orphan Drug Designation for Inflazome’s Inzomelid for the Treatment
    FDA Grants Orphan Drug Designation for Inflazome’s Inzomelid for the Treatment

    14 Jul 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200713005569/en

    BUSINESSWIRE
    14 Jul 2020
    Share Share
    Inzomelid completes Ph I studies and shows +ve results treatment of Cryopyrin
    Inzomelid completes Ph I studies and shows +ve results treatment of Cryopyrin

    26 Mar 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200326005102/en

    BUSINESSWIRE
    26 Mar 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search